| Oct 30 |
Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual ESPE Meeting 2024
|
| Sep 25 |
Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024
|
| Sep 5 |
Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024
|
| Aug 15 |
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
|
| Jul 31 |
Lumos Pharma Q2 2024 Earnings Preview
|
| Jun 4 |
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
|
